BONFANTI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 10.765
EU - Europa 7.855
AS - Asia 4.225
SA - Sud America 424
AF - Africa 55
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.339
Nazione #
US - Stati Uniti d'America 10.595
IT - Italia 2.180
SG - Singapore 2.109
RU - Federazione Russa 1.425
DE - Germania 1.398
IE - Irlanda 942
SE - Svezia 912
HK - Hong Kong 881
CN - Cina 384
ID - Indonesia 374
BR - Brasile 359
GB - Regno Unito 229
AT - Austria 154
VN - Vietnam 146
NL - Olanda 118
CA - Canada 113
FI - Finlandia 109
IN - India 107
UA - Ucraina 107
FR - Francia 72
TR - Turchia 58
RO - Romania 49
MX - Messico 43
PH - Filippine 27
ES - Italia 23
BE - Belgio 22
CZ - Repubblica Ceca 22
JP - Giappone 21
CO - Colombia 20
PK - Pakistan 17
IR - Iran 16
CL - Cile 13
AR - Argentina 12
GR - Grecia 12
CH - Svizzera 11
DK - Danimarca 11
ZA - Sudafrica 11
KE - Kenya 10
BG - Bulgaria 9
KR - Corea 9
LT - Lituania 7
PE - Perù 7
PL - Polonia 7
TH - Thailandia 7
AL - Albania 6
AU - Australia 6
BD - Bangladesh 6
JO - Giordania 6
MY - Malesia 6
NZ - Nuova Zelanda 6
EC - Ecuador 5
IL - Israele 5
IQ - Iraq 5
KZ - Kazakistan 5
MA - Marocco 5
SA - Arabia Saudita 5
SC - Seychelles 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
EG - Egitto 4
BY - Bielorussia 3
EE - Estonia 3
GH - Ghana 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
MU - Mauritius 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
PY - Paraguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
HU - Ungheria 2
LV - Lettonia 2
MM - Myanmar 2
NG - Nigeria 2
OM - Oman 2
PR - Porto Rico 2
SN - Senegal 2
TN - Tunisia 2
UG - Uganda 2
UY - Uruguay 2
A1 - Anonimo 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BW - Botswana 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
IS - Islanda 1
Totale 23.325
Città #
Ann Arbor 2.463
Singapore 1.491
Frankfurt am Main 1.149
Dublin 914
Hong Kong 877
Fairfield 781
Chandler 748
New York 589
Santa Clara 569
Milan 517
Ashburn 469
Wilmington 409
Woodbridge 403
Princeton 385
Jakarta 366
Houston 359
Seattle 301
Cambridge 223
Altamura 206
Lawrence 179
San Diego 114
Dong Ket 109
Nuremberg 107
London 91
Shanghai 90
Moscow 88
Vienna 88
Rome 78
Jacksonville 77
Helsinki 67
Chicago 62
Andover 61
Guangzhou 57
Dearborn 54
Boardman 48
Falls Church 44
Los Angeles 44
Pune 44
Galati 43
Toronto 42
Fremont 36
Monza 36
Council Bluffs 34
Beijing 32
Nanjing 31
Florence 27
Lappeenranta 27
São Paulo 26
Norwalk 24
Lissone 23
Turin 21
Brussels 20
Ottawa 20
Naples 19
Washington 19
Brno 17
Cuauhtémoc 17
Palermo 17
Bogotá 16
Brescia 16
Lachine 15
Shenzhen 15
Istanbul 14
Munich 14
Rio de Janeiro 14
Belo Horizonte 13
Dallas 13
Hangzhou 13
Padova 13
Redmond 13
Carate Brianza 12
Jinan 12
Busto Arsizio 11
Genoa 11
Groningen 11
Hyderabad 11
Mexico City 11
Seregno 11
Amsterdam 10
Bari 10
Bologna 10
Kilburn 10
Kocaeli 10
Kolkata 10
Manila 10
Paris 10
Pisa 10
Romola 10
Acquafredda 9
Huizen 9
Nairobi 9
San Francisco 9
Tokyo 9
Zurich 9
Athens 8
Catania 8
Cologno Monzese 8
Desio 8
Lahore 8
Perugia 8
Totale 15.713
Nome #
Methotrexate inhibits SARS-CoV-2 virus replication "in vitro" 431
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 369
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 257
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 242
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 241
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 221
A second update on mapping the human genetic architecture of COVID-19 215
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting 211
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 210
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 207
An immune-based biomarker signature is associated with mortality in COVID-19 patients 203
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 201
Mapping the human genetic architecture of COVID-19 200
Delirium in Patients with SARS‐CoV‐2 Infection: A Multicenter Study 199
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 198
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 190
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 190
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy 189
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 188
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 185
High rates of 30-day mortality in patients with cirrhosis and COVID-19 184
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 179
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 178
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 175
Infezione disseminata da Mycobacterium avium complex con batteriemia persistente in un paziente AIDS-presenter [Disseminated Mycobacterium avium complex infection with persistent bacteremia in an AIDS-presenter patient] 174
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study 174
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 169
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 169
Alternative pre-analytical strategies for SARS CoV 2 RNA detection 167
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 165
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 161
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) 159
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 157
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 156
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 155
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 155
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 154
HIV and metabolic syndrome - A comparison with the general population 144
Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study 144
The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: A randomized multicentric study 142
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 142
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 140
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 140
Anti-SARS-CoV-2 IgG antibodies induced by the BNT162b2 mRNA vaccine is age-dependent and influenced by a previous natural SARS-CoV-2 infection 135
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 134
Assessing the mortality risk in older patients hospitalized with a diagnosis of sepsis: the role of frailty and acute organ dysfunction 134
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 133
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID study 133
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 132
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 132
Streptococcus agalactiae infective endocarditis complicated by multiple mycotic hepatic aneurysms and massive splenic infarction: A case report 126
Beware of biases in observational studies on anti-spike monoclonal antibodies 123
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 122
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 121
Frailty index predicts poor outcome in COVID-19 patients 121
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 117
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 117
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 117
A multidisciplinary approach to screen the post-COVID-19 conditions 116
Atrial Fibrillation Incidence in SARS-COV-2 Infected Patients: Predictors and Relationship with in-Hospital Mortality 115
Being a Doctor Will Never Be the Same After the COVID-19 Pandemic 114
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible from the STOPSHIV Project Cohort 114
Steroids in severe COVID-19 patients: A retrospective analysis on the first pandemics in Lombardy 113
Pillars of long-term antiretroviral therapy success 112
Weight gain: A possible side effect of all antiretrovirals 112
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients 111
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 109
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 108
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 106
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 105
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 103
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 103
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 102
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 101
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 101
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 101
Factors Associated With Weight Gain in People Treated With Dolutegravir 100
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: A longitudinal study 99
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 99
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 99
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 97
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 96
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 96
Factors associated with hospital admission for COVID-19 in HIV patients 94
Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: A multicentric case-control study 93
Compassionate Use of Remdesivir in Children With Severe COVID-19 92
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 91
Atrial fibrillation and clinical outcomes in a cohort of hospitalized patients with sars-cov-2 infection and chronic kidney disease 89
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 89
Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19 89
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 87
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: A budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy) 86
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 86
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 85
One-year survival and Quality of Life of first wave COVID-19 invasively ventilated patients in Lombardy, Italy 83
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 83
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? 82
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 81
HEFFICON: HIV effectiveness Italian conference 81
Il linfoma di Hodgkin nei soggetti con infezione da HIV 81
Totale 14.231
Categoria #
all - tutte 120.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020261 0 0 0 0 0 0 0 0 0 24 101 136
2020/20213.854 91 158 232 319 314 410 248 385 518 394 329 456
2021/20222.857 306 319 311 238 160 207 117 201 169 124 194 511
2022/20234.492 587 1.070 440 387 359 707 98 236 290 71 136 111
2023/20243.837 150 117 223 136 475 923 622 127 358 147 80 479
2024/20257.876 646 1.407 679 529 847 706 757 331 1.009 965 0 0
Totale 24.324